nadolol

Generic: nadolol

Labeler: cipla usa inc.
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name nadolol
Generic Name nadolol
Labeler cipla usa inc.
Dosage Form TABLET
Routes
ORAL
Active Ingredients

nadolol 20 mg/1

Manufacturer
Cipla USA Inc.

Identifiers & Regulatory

Product NDC 69097-867
Product ID 69097-867_39a5df9f-6bc8-480f-84a6-d051d2cef465
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA203455
Listing Expiration 2026-12-31
Marketing Start 2016-02-23

Pharmacologic Class

Established (EPC)
beta-adrenergic blocker [epc]
Mechanism of Action
adrenergic beta-antagonists [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 69097867
Hyphenated Format 69097-867

Supplemental Identifiers

RxCUI
198006 198007 198008
UPC
0369097867072 0369097869076 0369097868079
UNII
FEN504330V
NUI
N0000000161 N0000175556

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name nadolol (source: ndc)
Generic Name nadolol (source: ndc)
Application Number ANDA203455 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 20 mg/1
source: ndc
Packaging
  • 30 TABLET in 1 BOTTLE (69097-867-02)
  • 100 TABLET in 1 BOTTLE (69097-867-07)
  • 1000 TABLET in 1 BOTTLE (69097-867-15)
source: ndc

Packages (3)

69097-867-02 30 TABLET in 1 BOTTLE (69097-867-02) 69097-867-07 100 TABLET in 1 BOTTLE (69097-867-07) 69097-867-15 1000 TABLET in 1 BOTTLE (69097-867-15)

Ingredients (1)

nadolol (20 mg/1)

Linked Drug Pages (1)

Nadolol ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "39a5df9f-6bc8-480f-84a6-d051d2cef465", "openfda": {"nui": ["N0000000161", "N0000175556"], "upc": ["0369097867072", "0369097869076", "0369097868079"], "unii": ["FEN504330V"], "rxcui": ["198006", "198007", "198008"], "spl_set_id": ["c899eedb-4113-45da-acc3-8e181250a7d8"], "pharm_class_epc": ["beta-Adrenergic Blocker [EPC]"], "pharm_class_moa": ["Adrenergic beta-Antagonists [MoA]"], "manufacturer_name": ["Cipla USA Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET in 1 BOTTLE (69097-867-02)", "package_ndc": "69097-867-02", "marketing_start_date": "20160223"}, {"sample": false, "description": "100 TABLET in 1 BOTTLE (69097-867-07)", "package_ndc": "69097-867-07", "marketing_start_date": "20160223"}, {"sample": false, "description": "1000 TABLET in 1 BOTTLE (69097-867-15)", "package_ndc": "69097-867-15", "marketing_start_date": "20160223"}], "brand_name": "Nadolol", "product_id": "69097-867_39a5df9f-6bc8-480f-84a6-d051d2cef465", "dosage_form": "TABLET", "pharm_class": ["Adrenergic beta-Antagonists [MoA]", "beta-Adrenergic Blocker [EPC]"], "product_ndc": "69097-867", "generic_name": "Nadolol", "labeler_name": "Cipla USA Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Nadolol", "active_ingredients": [{"name": "NADOLOL", "strength": "20 mg/1"}], "application_number": "ANDA203455", "marketing_category": "ANDA", "marketing_start_date": "20160223", "listing_expiration_date": "20261231"}